Navigation path


Targeted stakeholder consultation on the draft Guidelines on Good Clinical Practice for Advanced Therapy Medicinal Products

Targeted stakeholders: The stakeholders involved in the clinical trials of advanced therapy medicinal products ("ATMPs"). Comments from small and medium-sized enterprises (SMEs), academia, hospitals and patient organisations are particularly welcome.

Deadline for participating: 31 October 2018